Fortress REIT Limited (FFB.JO)
ZAc 2024.0
(2.43%)
ZAc 2024.0
(2.43%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.06 Billion | 721.82 Million | 1.31 Billion | 1.18 Billion | 579.93 Million | -1.29 Billion |
| Net Income | 4.33 Billion | 5.91 Billion | 844.86 Million | 3.37 Billion | -8.36 Billion | 3.06 Billion |
| Depreciation & Amortization | 35.61 Million | 22.09 Million | 21.52 Million | 37.49 Million | 39.58 Million | 34.21 Million |
| Deferred income taxes | - | -22.09 Million | -21.52 Million | -3.09 Billion | 7.57 Billion | -5.21 Billion |
| Stock-based compensation | 93.79 Million | 55.57 Million | 49.17 Million | 45.75 Million | 52.76 Million | 37.13 Million |
| Change in working capital | 256.24 Million | -320.61 Million | -18.73 Million | 19.91 Million | 230.29 Million | 2.35 Million |
| Other non-cash items | -3.78 Billion | -4.93 Billion | 442.29 Million | 800.62 Million | 1.04 Billion | 786.76 Million |
| Investing Cash Flow | -1 Billion | -1 Billion | -3.13 Billion | -1 Billion | 291.42 Million | 2.22 Billion |
| Investments in PPE | -2.3 Billion | -2.21 Billion | -2.07 Billion | -360.88 Million | -260.63 Million | -1.07 Billion |
| Acquisitions | - | 42.01 Million | 53.17 Million | 153.36 Million | 322.61 Million | 674.58 Million |
| Investment purchases | -500 Million | -209.24 Million | -205.2 Million | -848.26 Million | -214.25 Million | -405.14 Million |
| Sales/Maturities of investments | 1.72 Billion | 1.36 Billion | 630.42 Million | 50.19 Million | 442.98 Million | 170.79 Million |
| Other Investing Activities | 66.8 Million | 14.92 Million | -1.53 Billion | -3.07 Million | 714 Thousand | 2.85 Billion |
| Financing Cash Flow | 1.92 Billion | -205.6 Million | 1.96 Billion | -115.76 Million | -395.95 Million | -1.6 Billion |
| Debt repayment | -2.6 Billion | -201.98 Million | -2.43 Billion | -113.47 Million | -395.89 Million | -1.05 Billion |
| Dividends payments | -633.51 Million | -3.61 Million | -879.35 Million | -281.32 Million | -1.58 Billion | -3.49 Billion |
| Common Stock Repurchased | - | - | -462.36 Million | - | -64 Thousand | -543.33 Million |
| Common Stock Issuance | - | - | -1.55 Billion | - | - | 4.55 Billion |
| Other Financing Activities | -49.39 Million | -3.61 Million | 6.41 Billion | -2.29 Million | -64 Thousand | -4.55 Billion |
| Accounts receivables | 107.09 Million | -136.71 Million | -212.16 Million | -58.72 Million | 13.24 Million | -48.64 Million |
| Accounts payables | 149.15 Million | -183.89 Million | 193.42 Million | 78.63 Million | 217.04 Million | 50.99 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 208.45 Million | 693.6 Million | 543.01 Million | 486.92 Million | 11.51 Million | 676.85 Million |
| Cash at end of period | 2.18 Billion | 208.45 Million | 693.6 Million | 543.01 Million | 486.92 Million | 11.51 Million |
| Capital Expenditure | -2.3 Billion | -2.21 Billion | -2.07 Billion | -360.88 Million | -260.63 Million | -1.07 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.97 Billion | -485.15 Million | 150.58 Million | 56.09 Million | 475.4 Million | -665.33 Million |
| Free Cash Flow | -1.23 Billion | -1.49 Billion | -762.22 Million | 819.63 Million | 319.29 Million | -2.36 Billion |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.33 Billion | 685.89 Million | 685.89 Million | 2.96 Billion | 1.48 Billion | 5.91 Billion |
| Depreciation & Amortization | - | 17.8 Million | 17.8 Million | - | - | 22.09 Million |
| Deferred income taxes | - | - | - | - | - | -22.09 Million |
| Stock-based compensation | - | 10.01 Million | 10.01 Million | 36.88 Million | 36.88 Million | 55.57 Million |
| Change in working capital | 256.24 Million | 53.54 Million | 53.54 Million | - | - | -320.61 Million |
| Other non-cash items | -3.78 Billion | -324.85 Million | -324.85 Million | -2.7 Billion | -1.35 Billion | -4.93 Billion |
| Investing Cash Flow | -1 Billion | -115.78 Million | -115.78 Million | -854.87 Million | -461.56 Million | -1 Billion |
| Investments in PPE | -2.3 Billion | -897.57 Million | - | -1.4 Billion | - | -2.21 Billion |
| Acquisitions | - | - | - | - | - | 42.01 Million |
| Investment purchases | -500 Million | - | - | -500 Million | - | -209.24 Million |
| Sales/Maturities of investments | 1.72 Billion | 692.71 Million | - | 1.03 Billion | - | 1.36 Billion |
| Other Investing Activities | 66.8 Million | -115.78 Million | -115.78 Million | 11.75 Million | -461.56 Million | 14.92 Million |
| Financing Cash Flow | 1.92 Billion | 633.81 Million | 633.81 Million | 655.44 Million | 327.72 Million | -205.6 Million |
| Debt repayment | -2.6 Billion | -1.95 Billion | - | -655.7 Million | - | -201.98 Million |
| Dividends payments | -633.51 Million | -633.26 Million | -316.63 Million | -257 Thousand | -128.5 Thousand | -3.61 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -49.39 Million | 950.44 Million | 950.44 Million | 327.85 Million | 327.85 Million | -3.61 Million |
| Accounts receivables | 107.09 Million | 53.54 Million | 53.54 Million | - | - | -136.71 Million |
| Accounts payables | 149.15 Million | - | - | - | - | -183.89 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 208.45 Million | 267.55 Million | - | 208.45 Million | - | 693.6 Million |
| Cash at end of period | 2.18 Billion | 2.18 Billion | 960.43 Million | 267.55 Million | 29.54 Million | 208.45 Million |
| Capital Expenditure | -2.3 Billion | -897.57 Million | - | -1.4 Billion | - | -2.21 Billion |
| Effect of forex changes on cash | - | - | - | 1.00 | - | - |
| Net cash flow / Change in cash | 1.97 Billion | 1.92 Billion | 960.43 Million | 59.09 Million | 29.54 Million | -485.15 Million |
| Free Cash Flow | -1.23 Billion | -455.16 Million | 442.4 Million | -1.14 Billion | 163.38 Million | -1.49 Billion |
FMCCT
2136
HPURF
PMTA
3563
HEMO